S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)
S&P 500   4,966.57 (-0.89%)
DOW   37,949.61 (+0.46%)
QQQ   414.40 (-2.13%)
AAPL   165.07 (-1.18%)
MSFT   399.32 (-1.22%)
META   481.12 (-4.12%)
GOOGL   153.90 (-1.35%)
AMZN   174.24 (-2.78%)
TSLA   146.99 (-1.96%)
NVDA   769.04 (-9.17%)
AMD   146.04 (-5.83%)
NIO   3.81 (-4.75%)
BABA   69.08 (+0.29%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.18 (-5.14%)
GE   148.36 (-2.99%)
CGC   7.99 (+2.04%)
DIS   112.17 (-0.23%)
AMC   3.21 (+9.93%)
PFE   25.96 (+2.24%)
PYPL   61.86 (-0.39%)
XOM   119.87 (+1.14%)
Free Trial
ASX:MVP

Medical Developments International (MVP) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free MVP Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
169,499 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
0.77%
Price Target
N/A
Stock Analysis
Stock Analysis
MVP stock logo

About Medical Developments International Stock (ASX:MVP)

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices. The company also provides asthma and COPD products, such as space chambers and silicone face masks. The company was founded in 1971 and is headquartered in Scoresby, Australia.

MVP Stock News Headlines

April 13, 2024 | msn.com
Bills Legend O.J. Simpson Dies at 76
April 10, 2024 | sports.yahoo.com
2024 Olympics Games in Paris - Yahoo Sports
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
April 7, 2024 | msn.com
Meet the Globe’s all-time All-Scholastic hockey teams
April 2, 2024 | finance.yahoo.com
Are Investors Undervaluing Medical Developments International Limited (ASX:MVP) By 48%?
March 28, 2024 | msn.com
Concussion prevention and treatment protocols earn Dr. Mark Aubry induction into Ottawa Sports Hall of Fame
March 14, 2024 | msn.com
Dolphins add intriguing tight end talent who spent five years with Kansas City Chiefs
March 14, 2024 | msn.com
Introducing the 17 girls basketball players nominated for the 2024 Dave Cowens Award
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
March 12, 2024 | finance.yahoo.com
Electronic Medical Records Market to Surpass $46.96 Billion by 2028, Lead by Asia-Pacific Growth and AI Trends
March 7, 2024 | msn.com
Google Gemini is 'the tip of the iceberg': AI bias can have 'devastating impact' on humanity, say experts
February 24, 2024 | msn.com
Govt looks to private sector in medical imports reduction efforts
February 23, 2024 | msn.com
Texans Sign Defensive End Marcus Haynes
February 23, 2024 | msn.com
Is Ex NFL Star Adrian Peterson Auctioning Off Accolades?
February 21, 2024 | finance.yahoo.com
Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?
February 19, 2024 | msn.com
Medical device sector expected to contribute RM20 billion to economy this year
February 14, 2024 | finance.yahoo.com
Medical Developments International Limited (MVP.XA)
February 6, 2024 | msn.com
Former Texans Coach Tim Kelly Finds a New Job
February 4, 2024 | omaha.com
'Friend of Ukraine': Warren Buffett's son provides $500 million in humanitarian aid
January 16, 2024 | bizjournals.com
MVP Health Care appoints prominent executive to its board
January 10, 2024 | morningstar.com
Medical Developments International Ltd MVP
January 3, 2024 | finance.yahoo.com
Medical Developments International (ASX:MVP) shareholders are up 36% this past week, but still in the red over the last three years
September 10, 2023 | finance.yahoo.com
MVP.AX - Medical Developments International Limited
July 13, 2023 | msn.com
At 77, MVP has not stopped dreaming of a better future for all
June 30, 2023 | msn.com
Jaden Smith says psychedelics made him more empathetic. Here’s what the experts say.
June 8, 2023 | finance.yahoo.com
Medical Developments International Limited's (ASX:MVP) Price Is Right But Growth Is Lacking
May 3, 2023 | fool.com.au
Medical Developments International share price charges higher on Mundipharma deal
See More Headlines
Receive MVP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medical Developments International and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
ASX:MVP
CUSIP
N/A
CIK
N/A
Web
www.medicaldev.com
Phone
61 3 9547 1888
Fax
N/A
Employees
68
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-19,210,000.00
Net Margins
-57.27%
Pretax Margin
N/A
Return on Equity
-23.42%
Return on Assets
-13.86%

Debt

Debt-to-Equity Ratio
3.20
Current Ratio
2.78
Quick Ratio
2.54

Sales & Book Value

Annual Sales
$33.55 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
21.37
Book Value
A$0.88 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
86,310,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.61
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Brent MacGregor (Age 60)
    Chief Executive Officer
    Comp: $758.49k
  • Ms. Anita James
    Chief Financial Officer
  • Matthew Cramer
    Chief of Operations & Supply Chain
  • Ms. Tara Eaton
    General Counsel & Company Secretary
  • Dr. Scott Courtney
    Chief Scientific Officer
  • Wai Ng Chi
    Head of Regulatory Affairs
  • Wayne Pearce
    Head of Production
  • Mr. Stefaan Schatteman
    Head of Europe

Key Competitors

View All Competitors

Insiders


MVP Stock Analysis - Frequently Asked Questions

Is Medical Developments International a good dividend stock?

Medical Developments International (ASX:MVP) pays an annual dividend of A$0.04 per share and currently has a dividend yield of 0.77%.
Read our dividend analysis for MVP.

What other stocks do shareholders of Medical Developments International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Developments International investors own include Talon Energy (TPD), Mesoblast (MESO), Gold Road Resources (GOR), Elixinol Wellness (ELLXF), Core Lithium (CXO) and Bubs Australia (BUB).

This page (ASX:MVP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press